653 related articles for article (PubMed ID: 34559989)
1. Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming.
Morrissey SM; Zhang F; Ding C; Montoya-Durango DE; Hu X; Yang C; Wang Z; Yuan F; Fox M; Zhang HG; Guo H; Tieri D; Kong M; Watson CT; Mitchell RA; Zhang X; McMasters KM; Huang J; Yan J
Cell Metab; 2021 Oct; 33(10):2040-2058.e10. PubMed ID: 34559989
[TBL] [Abstract][Full Text] [Related]
2. NLRP6 is required for cancer-derived exosome-modified macrophage M2 polarization and promotes metastasis in small cell lung cancer.
Rao X; Zhou X; Wang G; Jie X; Xing B; Xu Y; Chen Y; Li J; Zhu K; Wu Z; Wu G; Wu C; Zhou R
Cell Death Dis; 2022 Oct; 13(10):891. PubMed ID: 36270983
[TBL] [Abstract][Full Text] [Related]
3. Exosomes-mediated tumor metastasis through reshaping tumor microenvironment and distant niche.
Luo X; Li Y; Hua Z; Xue X; Wang X; Pang M; Xiao C; Zhao H; Lyu A; Liu Y
J Control Release; 2023 Jan; 353():327-336. PubMed ID: 36464063
[TBL] [Abstract][Full Text] [Related]
4. Cancer-derived exosomal TRIM59 regulates macrophage NLRP3 inflammasome activation to promote lung cancer progression.
Liang M; Chen X; Wang L; Qin L; Wang H; Sun Z; Zhao W; Geng B
J Exp Clin Cancer Res; 2020 Aug; 39(1):176. PubMed ID: 32867817
[TBL] [Abstract][Full Text] [Related]
5. Tumor-derived exosomal circFARSA mediates M2 macrophage polarization via the PTEN/PI3K/AKT pathway to promote non-small cell lung cancer metastasis.
Chen T; Liu Y; Li C; Xu C; Ding C; Chen J; Zhao J
Cancer Treat Res Commun; 2021; 28():100412. PubMed ID: 34119765
[TBL] [Abstract][Full Text] [Related]
6. Reactive oxygen species reprogram macrophages to suppress antitumor immune response through the exosomal miR-155-5p/PD-L1 pathway.
Li X; Wang S; Mu W; Barry J; Han A; Carpenter RL; Jiang BH; Peiper SC; Mahoney MG; Aplin AE; Ren H; He J
J Exp Clin Cancer Res; 2022 Jan; 41(1):41. PubMed ID: 35086548
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of kras-derived exosomes downregulates immunosuppressive BACH2/GATA-3 expression via RIP-3 dependent necroptosis and miR-146/miR-210 modulation.
Petanidis S; Domvri K; Porpodis K; Anestakis D; Freitag L; Hohenforst-Schmidt W; Tsavlis D; Zarogoulidis K
Biomed Pharmacother; 2020 Feb; 122():109461. PubMed ID: 31918262
[TBL] [Abstract][Full Text] [Related]
8. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
[TBL] [Abstract][Full Text] [Related]
9. YKT6 expression, exosome release, and survival in non-small cell lung cancer.
Ruiz-Martinez M; Navarro A; Marrades RM; Viñolas N; Santasusagna S; Muñoz C; Ramírez J; Molins L; Monzo M
Oncotarget; 2016 Aug; 7(32):51515-51524. PubMed ID: 27285987
[TBL] [Abstract][Full Text] [Related]
10. Glycolytic activation of peritumoral monocytes fosters immune privilege via the PFKFB3-PD-L1 axis in human hepatocellular carcinoma.
Chen DP; Ning WR; Jiang ZZ; Peng ZP; Zhu LY; Zhuang SM; Kuang DM; Zheng L; Wu Y
J Hepatol; 2019 Aug; 71(2):333-343. PubMed ID: 31071366
[TBL] [Abstract][Full Text] [Related]
11. Kras-driven intratumoral heterogeneity triggers infiltration of M2 polarized macrophages via the circHIPK3/PTK2 immunosuppressive circuit.
Katopodi T; Petanidis S; Domvri K; Zarogoulidis P; Anestakis D; Charalampidis C; Tsavlis D; Bai C; Huang H; Freitag L; Hohenforst-Schmidt W; Matthaios D; Porpodis K
Sci Rep; 2021 Jul; 11(1):15455. PubMed ID: 34326381
[TBL] [Abstract][Full Text] [Related]
12. Lung Tumor Cell-Derived Exosomes Promote M2 Macrophage Polarization.
Pritchard A; Tousif S; Wang Y; Hough K; Khan S; Strenkowski J; Chacko BK; Darley-Usmar VM; Deshane JS
Cells; 2020 May; 9(5):. PubMed ID: 32456301
[TBL] [Abstract][Full Text] [Related]
13. Tumor associated macrophages-derived exosomes facilitate hepatocellular carcinoma malignance by transferring lncMMPA to tumor cells and activating glycolysis pathway.
Xu M; Zhou C; Weng J; Chen Z; Zhou Q; Gao J; Shi G; Ke A; Ren N; Sun H; Shen Y
J Exp Clin Cancer Res; 2022 Aug; 41(1):253. PubMed ID: 35986343
[TBL] [Abstract][Full Text] [Related]
14. Immune suppressed tumor microenvironment by exosomes derived from gastric cancer cells via modulating immune functions.
Liu J; Wu S; Zheng X; Zheng P; Fu Y; Wu C; Lu B; Ju J; Jiang J
Sci Rep; 2020 Sep; 10(1):14749. PubMed ID: 32901082
[TBL] [Abstract][Full Text] [Related]
15. Tumor-Derived RAB21+ABHD12+ sEVs Drive the Premetastatic Microenvironment in the Lung.
Wu K; Li Y; Ji Y; Liu C; Wang X; Guo H; Zhang J; He Y
Cancer Immunol Res; 2024 Feb; 12(2):161-179. PubMed ID: 38215051
[TBL] [Abstract][Full Text] [Related]
16. Exosomal communication by metastatic osteosarcoma cells modulates alveolar macrophages to an M2 tumor-promoting phenotype and inhibits tumoricidal functions.
Wolf-Dennen K; Gordon N; Kleinerman ES
Oncoimmunology; 2020; 9(1):1747677. PubMed ID: 32313728
[TBL] [Abstract][Full Text] [Related]
17. Exosomes from Melatonin Treated Hepatocellularcarcinoma Cells Alter the Immunosupression Status through STAT3 Pathway in Macrophages.
Cheng L; Liu J; Liu Q; Liu Y; Fan L; Wang F; Yu H; Li Y; Bu L; Li X; Wei W; Wang H; Sun G
Int J Biol Sci; 2017; 13(6):723-734. PubMed ID: 28655998
[TBL] [Abstract][Full Text] [Related]
18. Role of tumour-derived exosomes in metastasis.
Bai S; Wei Y; Liu R; Xu R; Xiang L; Du J
Biomed Pharmacother; 2022 Mar; 147():112657. PubMed ID: 35078096
[TBL] [Abstract][Full Text] [Related]
19. Enhanced response to PD-L1 silencing by modulation of TME via balancing glucose metabolism and robust co-delivery of siRNA/Resveratrol with dual-responsive polyplexes.
Jia L; Gao Y; Zhou T; Zhao XL; Hu HY; Chen DW; Qiao MX
Biomaterials; 2021 Apr; 271():120711. PubMed ID: 33592352
[TBL] [Abstract][Full Text] [Related]
20. Expression of scavenger receptor MARCO defines a targetable tumor-associated macrophage subset in non-small cell lung cancer.
La Fleur L; Boura VF; Alexeyenko A; Berglund A; Pontén V; Mattsson JSM; Djureinovic D; Persson J; Brunnström H; Isaksson J; Brandén E; Koyi H; Micke P; Karlsson MCI; Botling J
Int J Cancer; 2018 Oct; 143(7):1741-1752. PubMed ID: 29667169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
